Pharmaceutical turmoil in the US is only temporary: Philips CEO
Turbulence and turmoil in the pharmaceutical industry will only prove to be temporary in spite of President-elect Donald Trump's vow to clamp down on drug pricing, according to Royal Philips' chief executive. Frans Van Houten, chief executive of the medical equipment and technology firm, described the current situation in the pharmaceutical industry as "uncertain" however he remained confident the negative sentiment surrounding healthcare stocks would be reversed in time.